Johnson & Johnson (J&J) is engaged in manufacturing and selling a broad range of healthcare products worldwide. The company focuses on the development of products related to health and well-being. J&J operates through three business segments, namely, Consumer, Pharmaceuticals, and Medical Devices and Diagnostics. The company's Consumer segment offers a wide range of health and personal care products in the beauty, skin care, nutritional, oral care, baby care, women's health and over-the-counter pharmaceutical products and wellness and prevention categories. Through its Pharmaceuticals segment, the company focuses on five therapeutic areas, namely, Neuroscience, Cardiovascular Disease and Metabolism, Immunology, Oncology and Infectious Disease. J&J's Medical Devices and Diagnostics segment provides an array of products to people who suffer from some of the most pervasive and chronic conditions. J&J conducts business through more than 250 operating companies located in 60 countries, including the US. The company is headquartered in New Jersey, the US.

Johnson & Johnson Key Recent Developments

Nov 04, 2011: European Commission Opens In-Depth Investigation Into Proposed Acquisition Of Synthes By Johnson and Johnson

Oct 18, 2011: Johnson & Johnson Reports Net Sales Of $16 Billion For Q3 2011

Oct 12, 2011: Los Angeles Jury Returns $48.2m Verdict Against Johnson & Johnson

Sep 28, 2011: Boston Scientific Announces Favorable Appellate Court Ruling Affirming Non-Infringement Of Johnson & Johnson Patent

Aug 04, 2011: Johnson & Johnson Pharmaceutical Research & Development Scientists Uncover Previously Unknown Role For Class Of Molecules

This comprehensive SWOT profile of Johnson & Johnson provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description - A detailed description of the company's operations and business divisions.
Corporate strategy - Analyst's summarization of the company's business strategy.
SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives' employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities - A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

This report covers the following industry codes:

SIC Code: 2834
NAICS Code: 325412

Section 1 - About the Company
- Johnson & Johnson - Key Facts
- Johnson & Johnson - Key Employees
- Johnson & Johnson - Key Employee Biographies
- Johnson & Johnson - Major Products and Services
- Johnson & Johnson - Pharmaceutical Pipeline Products Data
- Johnson & Johnson, Pipeline Products by Therapy Area
- Johnson & Johnson, Pipeline Products by Development Phase
- Johnson & Johnson - History
- Johnson & Johnson - Company Statement
- Johnson & Johnson - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
Section 2 - Company Analysis
- Johnson & Johnson - Business Description
- Business Description - Consumer
- Consumer - Overview
- Consumer - Financials
- Consumer - Technology
- Business Description - Medical Devices and Diagnostics
- Medical Devices and Diagnostics - Overview
- Medical Devices and Diagnostics - Financials
- Medical Devices and Diagnostics - Market View
- Medical Devices and Diagnostics - Technology
- Business Description - Pharmaceutical
- Pharmaceutical - Overview
- Pharmaceutical - Financials
- Pharmaceutical - Market View
- Pharmaceutical - Technology
- Johnson & Johnson - Corporate Strategy
- Johnson & Johnson - SWOT Analysis
- SWOT Analysis - Overview
- Johnson & Johnson - Strengths
- Strength - Strong In-house Research Capabilities
- Strength - Widespread Geographical Presence
- Strength - Diversified Product Offerings
- Strength - Strong Liquidity Position
- Johnson & Johnson - Weaknesses
- Weakness - Product Recalls
- Weakness - Patent Expiries
- Weakness - Decline in Revenues
- Weakness - Illegal Promotion of Topamax
- Johnson & Johnson - Opportunities
- Opportunity - Strategic Acquisitions
- Opportunity - New Product Launches and Strong Pipeline
- Opportunity - Global Pharmaceutical Market
- Opportunity - Growth in the Prevalence of Cancer
- Opportunity - Changing Demographics
- Johnson & Johnson - Threats
- Threat - Litigation and Legal Claims
- Threat - Regulatory Requirements
- Threat - Competitive Pressures
- Threat - Increased Pricing Control
- Johnson & Johnson - Key Competitors
Section 3 - Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
Section 4 - Company's Lifesciences, Power Financial Deals and Alliances
- Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
- Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
- Johnson & Johnson, Medical Equipment, Deals By Year, 2005 to YTD 2011
- Johnson & Johnson, Medical Equipment, Deals By Type, 2005 to YTD 2011
- Johnson & Johnson, Power, Deals By Year, 2005 to YTD 2011
- Johnson & Johnson, Power, Deals By Type, 2005 to YTD 2011
- Johnson & Johnson, Recent Deals Summary
Section 5 - Company's Recent Developments
- Johnson & Johnson, Recent Developments
- Nov 04, 2011: European Commission Opens In-Depth Investigation Into Proposed Acquisition Of Synthes By Johnson and Johnson
- Oct 18, 2011: Johnson & Johnson Reports Net Sales Of $16 Billion For Q3 2011
- Oct 12, 2011: Los Angeles Jury Returns $48.2m Verdict Against Johnson & Johnson
- Sep 28, 2011: Boston Scientific Announces Favorable Appellate Court Ruling Affirming Non-Infringement Of Johnson & Johnson Patent
- Aug 04, 2011: Johnson & Johnson Pharmaceutical Research & Development Scientists Uncover Previously Unknown Role For Class Of Molecules
- Jul 19, 2011: Johnson & Johnson Reports Net Sales Of $16.6 Billion For Q2 2011
- Jun 22, 2011: Johnson & Johnson Opens Innovation Center In China
- Jun 14, 2011: Johnson & Johnson Appoints Ronald Williams To Board
- May 24, 2011: Jensen Law Firm Announces $10m Verdict Against Johnson & Johnson Unit For Toxic Motrin Reaction
- Apr 19, 2011: Johnson & Johnson Reports Net Income Of $3.5 Billion For Q1 2011
Section 6 - Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
List of Tables
- Johnson & Johnson, Key Facts
- Johnson & Johnson, Key Employees
- Johnson & Johnson, Key Employee Biographies
- Johnson & Johnson, Major Products and Services
- Johnson & Johnson, Number of Pipeline Products by Therapy Area
- Johnson & Johnson, Number of Pipeline Products by Development Stage
- Johnson & Johnson, Pipeline Products By Therapy Area and Development Phase
- Johnson & Johnson, History
- Johnson & Johnson, Subsidiaries
- Johnson & Johnson, Key Competitors
- Johnson & Johnson, Ratios based on current share price
- Johnson & Johnson, Annual Ratios
- Johnson & Johnson, Interim Ratios
- Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
- Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Type, 2005 to YTD 2011
- Johnson & Johnson, Medical Equipment, Deals By Year, 2005 to YTD 2011
- Johnson & Johnson, Medical Equipment, Deals By Type, 2005 to YTD 2011
- Johnson & Johnson, Power, Deals By Year, 2005 to YTD 2011
- Johnson & Johnson, Power, Deals By Type, 2005 to YTD 2011
- Johnson & Johnson, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
List of Figures
- Johnson & Johnson, Pipeline Products by Therapy Area
- Johnson & Johnson, Pipeline Products by Development Phase
- Johnson & Johnson, Performance Chart (2006 - 2010)
- Johnson & Johnson, Ratio Charts
- Johnson & Johnson, Pharmaceuticals & Healthcare, Deals By Year, 2005 to YTD 2011
- Johnson & Johnson, Pharmaceuticals & Healthcare, Deals by Type, 2005 to YTD 2011
- Johnson & Johnson, Medical Equipment, Deals By Year, 2005 to YTD 2011
- Johnson & Johnson, Medical Equipment, Deals by Type, 2005 to YTD 2011
- Johnson & Johnson, Power, Deals By Year, 2005 to YTD 2011
- Johnson & Johnson, Power, Deals by Type, 2005 to YTD 2011

Pharmaceutical Market Research

Johnson & Johnson (JNJ)